FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2604001330> ?p ?o ?g. }

• W2604001330 endingPage "765" @default.
• W2604001330 startingPage "752" @default.
• W2604001330 abstract "Metoprolol and paroxetine/fluoxetine are inevitably co-prescribed because cardiovascular disorders and depression often coexist in the elderly. This leads to CYP2D6-mediated drug-drug interactions (DDI). Because systematic evaluations are lacking, we assessed the burden of metoprolol-paroxetine/fluoxetine interaction in the elderly and how these interactions are managed in Dutch community pharmacies.Dispensing data were collected from the University of Groningen pharmacy database (IADB.nl, 1999-2014) for elderly patients (≥60 years) starting beta-blockers and/or antidepressants. Based on the two main DDI alert systems (G-Standard and Pharmabase), incidences were divided between signalled (metoprolol-fluoxetine/paroxetine) and not-signalled (metoprolol-alternative antidepressants and alternative beta-blockers-paroxetine/fluoxetine) combinations. Incident users were defined as patients starting at least one signalled or a non-signalled combination. G-Standard signalled throughout the study period, whereas Pharmabase stopped after 2005.A total of 1763 patients had 2039 metoprolol-paroxetine/fluoxetine co-prescriptions, despite DDI alert systems, and about 57.3% were signalled. The number of metoprolol-alternative antidepressant combinations (incidences = 3150) was higher than alternative beta-blocker-paroxetine/fluoxetine combinations (incidences = 1872). Metoprolol users are more likely to be co-medicated with an alternative antidepressant (incidences = 2320) than paroxetine/fluoxetine users (incidences = 1232) are. The number of paroxetine/fluoxetine users co-prescribed with alternative beta-blockers was comparable to those co-medicated with metoprolol (about 50%). Less than 5% of patients received a substitute therapy after using metoprolol-paroxetine/fluoxetine. Most of the metoprolol users (90%) received a low dose (mean DDD = 0.47) regardless whether they were prescribed paroxetine/fluoxetine.Despite the signalling software, metoprolol-paroxetine/fluoxetine combinations are still observed in the elderly population. The clinical impact of these interactions needs further investigation. Copyright © 2017 John Wiley & Sons, Ltd." @default.
• W2604001330 created "2017-04-07" @default.
• W2604001330 creator A5033079155 @default.
• W2604001330 creator A5039076838 @default.
• W2604001330 creator A5070589057 @default.
• W2604001330 creator A5075477479 @default.
• W2604001330 creator A5091328827 @default.
• W2604001330 date "2017-03-26" @default.
• W2604001330 modified "2023-09-27" @default.
• W2604001330 title "The burden and management of cytochrome P450 2D6 (CYP2D6)-mediated drug-drug interaction (DDI): co-medication of metoprolol and paroxetine or fluoxetine in the elderly" @default.
• W2604001330 cites W1762915406 @default.
• W2604001330 cites W1892640469 @default.
• W2604001330 cites W1963614578 @default.
• W2604001330 cites W1969417922 @default.
• W2604001330 cites W1970773196 @default.
• W2604001330 cites W1981940524 @default.
• W2604001330 cites W1986685858 @default.
• W2604001330 cites W1987478360 @default.
• W2604001330 cites W1987819622 @default.
• W2604001330 cites W1992986601 @default.
• W2604001330 cites W1995878005 @default.
• W2604001330 cites W2002702566 @default.
• W2604001330 cites W2002972052 @default.
• W2604001330 cites W2004561313 @default.
• W2604001330 cites W2015988354 @default.
• W2604001330 cites W2018080987 @default.
• W2604001330 cites W2019954912 @default.
• W2604001330 cites W2021403976 @default.
• W2604001330 cites W2022641210 @default.
• W2604001330 cites W2023636483 @default.
• W2604001330 cites W2029436713 @default.
• W2604001330 cites W2037833111 @default.
• W2604001330 cites W2040679011 @default.
• W2604001330 cites W2044859414 @default.
• W2604001330 cites W2045654730 @default.
• W2604001330 cites W2051442292 @default.
• W2604001330 cites W2056824752 @default.
• W2604001330 cites W2058291849 @default.
• W2604001330 cites W2060447171 @default.
• W2604001330 cites W2060854717 @default.
• W2604001330 cites W2062120023 @default.
• W2604001330 cites W2063573369 @default.
• W2604001330 cites W2077205688 @default.
• W2604001330 cites W2085372582 @default.
• W2604001330 cites W2094628430 @default.
• W2604001330 cites W2104147835 @default.
• W2604001330 cites W2108129761 @default.
• W2604001330 cites W2110922423 @default.
• W2604001330 cites W2119132796 @default.
• W2604001330 cites W2119176600 @default.
• W2604001330 cites W2123808537 @default.
• W2604001330 cites W2124434896 @default.
• W2604001330 cites W2129754712 @default.
• W2604001330 cites W2134082391 @default.
• W2604001330 cites W2135064908 @default.
• W2604001330 cites W2147174572 @default.
• W2604001330 cites W2162251320 @default.
• W2604001330 cites W2165266539 @default.
• W2604001330 cites W2168134541 @default.
• W2604001330 cites W2168367580 @default.
• W2604001330 cites W2233935952 @default.
• W2604001330 cites W2280368342 @default.
• W2604001330 cites W2320195367 @default.
• W2604001330 cites W351118931 @default.
• W2604001330 cites W4248797945 @default.
• W2604001330 cites W4255897290 @default.
• W2604001330 doi "https://doi.org/10.1002/pds.4200" @default.
• W2604001330 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28345306" @default.
• W2604001330 hasPublicationYear "2017" @default.
• W2604001330 type Work @default.
• W2604001330 sameAs 2604001330 @default.
• W2604001330 citedByCount "20" @default.
• W2604001330 countsByYear W26040013302017 @default.
• W2604001330 countsByYear W26040013302018 @default.
• W2604001330 countsByYear W26040013302019 @default.
• W2604001330 countsByYear W26040013302020 @default.
• W2604001330 countsByYear W26040013302022 @default.
• W2604001330 countsByYear W26040013302023 @default.
• W2604001330 crossrefType "journal-article" @default.
• W2604001330 hasAuthorship W2604001330A5033079155 @default.
• W2604001330 hasAuthorship W2604001330A5039076838 @default.
• W2604001330 hasAuthorship W2604001330A5070589057 @default.
• W2604001330 hasAuthorship W2604001330A5075477479 @default.
• W2604001330 hasAuthorship W2604001330A5091328827 @default.
• W2604001330 hasBestOaLocation W26040013302 @default.
• W2604001330 hasConcept C126322002 @default.
• W2604001330 hasConcept C170493617 @default.
• W2604001330 hasConcept C2775864247 @default.
• W2604001330 hasConcept C2776134451 @default.
• W2604001330 hasConcept C2777828372 @default.
• W2604001330 hasConcept C2779177272 @default.
• W2604001330 hasConcept C2780035454 @default.
• W2604001330 hasConcept C2780980600 @default.
• W2604001330 hasConcept C2781161787 @default.
• W2604001330 hasConcept C2781280847 @default.
• W2604001330 hasConcept C33664856 @default.
• W2604001330 hasConcept C526171541 @default.
• W2604001330 hasConcept C62231903 @default.

• next